pimozide has been researched along with Atherosclerotic Parkinsonism in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (77.78) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Betz, AJ; Clark, K; Felsted, J; Font, L; Hockemeyer, J; Ishiwari, K; Korbey, S; Madson, L; Mirante, B; Muller, CE; Sager, TN; Salamone, JD | 1 |
Betz, A; Felsted, J; Ishiwari, K; Salamone, JD; Weber, S | 1 |
Annable, L; Chouinard, G | 1 |
Calne, DB; Claveria, LE; Haskayne, L; Lodge-Patch, IC; Pallis, CA; Petrie, A; Teychenne, PF | 1 |
Martin, IC | 1 |
Marsden, CD; Parkes, JD; Tarsy, D | 1 |
Arthurs, B; Codère, F; Dresner, S; Flanders, M; Gauthier, S; Stone, L | 1 |
Fog, R; Pakkenberg, H | 1 |
1 review(s) available for pimozide and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism.
Topics: Adenosine A2 Receptor Antagonists; Catalepsy; Humans; Jaw Diseases; Locomotion; Motor Activity; Movement Disorders; Parkinson Disease, Secondary; Pimozide; Purines; Tremor; Xanthines | 2008 |
6 trial(s) available for pimozide and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Pimozide in the treatment of newly admitted schizophrenic patients.
Topics: Acute Disease; Adult; Chlorpromazine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Pimozide; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1982 |
Tardive dyskinesia treated with pimozide.
Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Consciousness Disorders; Drug Therapy, Combination; Female; Fluphenazine; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease, Secondary; Perphenazine; Phenothiazines; Pimozide; Prochlorperazine; Promazine; Promethazine; Schizophrenia; Thioridazine | 1975 |
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pimozide; Placebos; Schizophrenia; Thioridazine; Trifluoperazine; Trifluperidol | 1975 |
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
Topics: Aged; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Secondary; Pimozide; Placebos; Promethazine | 1975 |
The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group.
Topics: Adolescent; Adult; Aged; Behavior; Female; Flupenthixol; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Pimozide; Prolactin; Schizophrenia; Schizophrenic Psychology; Thioxanthenes | 1987 |
Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.
Topics: Aged; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Mouth Diseases; Movement Disorders; Parkinson Disease, Secondary; Pimozide; Remission, Spontaneous; Salivary Gland Diseases; Tetrabenazine; Time Factors | 1974 |
2 other study(ies) available for pimozide and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Jaw; Male; Movement; Parkinson Disease, Secondary; Pimozide; Rats; Rats, Sprague-Dawley; Tremor | 2005 |
Treatment of blepharospasm with medication, surgery and type A botulinum toxin.
Topics: Baclofen; Blepharoptosis; Blepharospasm; Botulinum Toxins; Drug Evaluation; Eyelid Diseases; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Pimozide | 1987 |